U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199335) titled 'A Multi-center Assessment of an Intervention to Provide Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis to People Who Inject Drugs' on Sept. 22.
Brief Summary: The goal of this study is to determine the feasibility and impact of delivering long-acting injectable cabotegravir HIV pre-exposure prophylaxis and suite of support services to adults who inject non-prescription drugs who are risk for HIV through known sexual risk.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
HIV
Substance Use Disorder (SUD)
Injection Drug Use
Intervention:
DRUG: APRETUDE (cabotegravir)
All participants will be prescr...